Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-18 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease

Annals of Hematology

Volumn 79, Issue 3, 2000, Pages 110-113

  Bohlen, H ^a   Kessler, M ^b   Sextro, M ^b   Diehl, V ^b   Tesch, H ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cytokine; Hodgkin's disease; IL 10; Prognostic marker; Serum

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTOKINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; INTERLEUKIN 10; INTERLEUKIN 2; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREMEDICATION; PRIORITY JOURNAL; PROGNOSIS; TH1 CELL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; HODGKIN DISEASE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0034034187     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050564     Document Type: Article

References (13)

1. Foss HD, Herbst H, Oelmann E et al. (1993) Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. Br J Haematol 84:627-635
2. Frisan T, Sjoberg J, Dolcetti R et al. (1995) Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 86:1493-1501
3. Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin's Disease. N Engl J Med 339:1506-1514
4. Herbst H, Foss HD, Samol J et al. (1996) Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood 87:2918-2929
5. Hsu SM, Hsu PL (1994) Autocrine and paracrine functions of cytokines in malignant lymphomas. Biomed Pharmacother 48:433-444
6. Klein S, Jucker M, Diehl V, Tesch H (1992) Production of multiple cytokines by Hodgkin's disease derived cell lines. Hematol Oncol 10:319-329
7. Kretschmer C, Jones DB, Morrison K et al. (1990) Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease. Am J Pathol 137:341-351
8. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165-190
9. Mosmann TR (1994) Properties and functions of interleukin-10. Adv Immunol 56:1-26
10. Ohshima K, Suzumiya J, Akamatu M, Takeshita M, Kikuchi M (1995) Human and viral interleukin-10 in Hodgkin's disease, and its influence on CD4+ and CD8+ T lymphocytes. Int J Cancer 62:5-10
11. van der Poll T, Jansen J, Levi M, ten Cate H, ten Cate JW, van Deventer SI (1994) Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 180:1985-1988
12. Trumper L, Jung W, Dahl G, Diehl V, Gause A, Pfreundschuh M (1994) Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease. Ann Oncol 1:93-96
13. Xerri L, Birg F, Guigou V, Bouabdallah R, Poizot-Martin I, Hassoun I (1992) In situ expression of the IL-1-alpha and TNF-alpha genes by Reed-Sternberg cells in Hodgkin's disease. Int J Cancer 50:689-693